Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations

The aim of this work was to evaluate gellan gum as binder in pellet formulations, with theophylline as the model drug, in comparison with polyvinylpyrrolidone (PVP). A full 32 factorial design was realized, with binder and dilu- ent factors at three levels each. Pellets were produced by the extrusion/spheronization technique, and dried in a fluid- ized bed. Physical tests and dissolution tests were conducted. The results showed that the binder factor was not signifi- cant for pellet size and granulometry distribution. Rather, trends of a different response of gellan gum were identi- fied, in comparison with PVP, in aspect ratio and dissolu- tion tests: more round pellets were obtained in formula- tions with gellan gum, and more variable dissolution resulted when this polysaccharide was present. Therefore, if the usage of this compound in immediate release pellet formulations is verified, this justifies the interest in the de- velopment of sustained release systems using gellan gum.

Nordic Bioproducts Group opens its first major production facility for advanced cellulosic materials

Novel fast dissolving freeze dried sublingual baicalin tablets for enhanced hepatoprotective effect: in-vitro characterization, cell viability, and in-vivo evaluation

Preparation, Characterization, and Evaluation of a Novel Co-Processed Excipient as a Directly Compressible Vehicle in Antihypertensive Tablet Formulation

Download Article here: 9919.pdf